Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Stephen M. Dalby
Introduction
Stephen M. Dalby is a notable inventor based in Springfield Township, NJ, who has made significant contributions to the field of pharmaceuticals. With a focus on cancer treatment, his work has the potential to impact many lives.
Latest Patents
Dalby holds a patent for a synthetic pathway to belzutifan and crystalline phases of synthetic intermediates. This patent provides crystalline forms for certain synthetic intermediates used in the production of belzutifan, a HIF-2α inhibitor that is useful for treating cancer. The disclosure also outlines processes for isolating these crystalline forms, showcasing his innovative approach to drug development.
Career Highlights
Throughout his career, Dalby has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Werthenstein Biopharma GmbH. His experience in these organizations has allowed him to develop and refine his expertise in drug synthesis and formulation.
Collaborations
Dalby has collaborated with talented professionals in his field, including Clinton Scott Shultz and Chintal Desai. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Stephen M. Dalby is a distinguished inventor whose work in synthetic pathways for cancer treatment exemplifies innovation in pharmaceuticals. His contributions are paving the way for new therapeutic options in the fight against cancer.